Roche Venture Fund (investor - Corporate Investor)

roche.com

See something wrong or missing? Let us know

Offices:Basel, San Francisco

Roche Venture Fund is a Swiss, CHF 500M ($520M) corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients. The company invests in life science companies in both pharmaceuticals and diagnostics.

Average round investment:57.78M USD

Average number per year:1.6

Distribution: 2025 (2)2024 (1)2023 (3)2022 (1)2021 (2) See the entire list

Portfolio companies: Spain

Splice Bio Switzerland

GlycoEra

Mission Therapeutics See the entire list

Mostly invests in:

United Kingdom (3) Health services (10)

See the entire list